section name header

Pronunciation ⬇

ta-va-BOR-ole

Classifications ⬆ ⬇

Therapeutic Classification: antifungals

Pharmacologic Classification: oxaboroles

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Inhibits fungal protein synthesis via inhibition of aminoacyl-transfer ribonucleic acid synthetase.
Therapeutic effects:
  • Resolution of toenail fungus.

Spectrum:

Pharmacokinetics ⬆ ⬇

Absorption: Minimal absorption follows topical administration.

Distribution: Unknown.

Metabolism/Excretion: Extensively metabolized; metabolites are eliminated mostly in urine.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

(resolution of infection)

ROUTEONSETPEAKDURATION
Topicalunknownunknown48 wk‡

‡Length of treatment necessary for resolution of infection.



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Local: dermatitis, erythema, exfoliation, ingrown toenail

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆

Kerydin